Radotinib
Radotinib is a BCR-ABL1-specific second-generation tyrosine kinase inhibitor (TKI). Also inhibits PDGFR thereby blocking PDGFR-mediated signal transduction pathways. Displays antineoplastic activities.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog